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Using Northern blot analysis and immunoblotting techniques we report for the first time, that the neural cell adhesion molecule, N-CAM, is ex- 
pressed in human heart. We found several different N-CAM transcripts in human fetal (13-17 weeks gestation) and mature heart (left ventricle 
from a 5-year-old child). Northern blotting showed that a 5.2 kb transcript was the most abundant and progressively increased with age, both 
in fetal and mature heart. These transcripts may correspond with the different protein isoforms shown by immunoblotting. We also confirmed 
the presence of N-CAM in fetal and mature myocytes by immunohistochemical techniques, using a monoclonal antibody to human N-CAM. Ra 
suits demonstrated that N-CAM is mainly confined to the myocyte cell surface. 
N-CAM; Heart; Fetal human; Northern blotting 
1. INTRODUCTION 
Neural cell adhesion molecule (N-CAM) is one of a 
family of cell surface sialoglycoproteins which 
facilitates cell-cell adhesion [ 1,2]. It is predominantly 
expressed in neurons and striated muscle, but has also 
been shown to be present in cardiac myocytes both in 
the mouse [3] and the rat [4]. A number of distinct 
isoforms have been described and their pattern of ex- 
pression is known to be tissue-dependent [5]. This is ac- 
complished from a single copy gene by alternative RNA 
processing at the levels of splicing and polyadenylation. 
Three isoforms are present each in brain [6] (180 kDa, 
140 kDa and 120 kDa) and skeletal muscle [9] 
(155 kDa, 145 kDa, 125 kDa). The presence of two 
isoforms (150 kDa and 125 kDa) has been 
demonstrated in embryonic mouse heart; the larger 
component is lost soon after birth 131. Two isoforms 
(145 kDa and 105 kDa) are expressed in embryonic rat 
heart [4] with two new forms, 155 kDa (transiently) 
and 125 kDa (permanently), appearing after birth. In 
developing rodent brain and skeletal muscle, the ap- 
pearance of the 120 kDa and 125 kDa isoforms has 
been linked to mRNA species of 2.9 and 5.2 kb [8,9]. 
N-CAM levels are known to respond to physiological 
stimuli; although high levels of N-CAM are expressed 
in embryonic muscle, they are lost from extrajunctional 
sarcolemma in adult skeletal muscle, However, after 
denervation, N-CAM protein and mRNA expression is 
restimulated leading to the generalized distribution of 
N-CAM to muscle sarcolemma 181. No previous study 
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has demonstrated the presence of N-CAM isoforms 
and transcripts in fetal or mature human myocardium. 
The present study was designed to describe, in develop- 
ing human heart, the temporal pattern of the relative 
levels of N-CAM exuression in terms of its protein 
isoforms and mRNA- transcripts and 
immunohistochemically, the spatial 
myocyte N-CAM localization. 
to demonstrate, 
distribution of 
2. MATERIALS AND METHODS 
2.1. Northern blot analysis of N-CAM mRNA 
RNA was extracted from heart by homogenization in 6 M. 
guanidinium isothiocyanate solution followed by CsCl ultracen- 
trifugation [lo]. Samples of total RNA were extracted from human 
fetal hearts of various gestational ages and from the left and right 
ventricles of a 5-year-old patient with cystic fibrosis at the time of 
heart-lung transplantation. RNA was first denatured with formamide 
and formaldehyde, separated by electrophoresis on 1.5% agarose gels 
in formaldehyde and 1 x Mops buffer. Samples of RNA were 
transferred to nylon filters (Genescreen, DuPont) in 25 mM 
NaHzP04/NazHP04 (pH 6.5). Filters were then washed with the 
same buffer for 15 min and prehybridized for 16 h at 42°C in 50% 
formamide, 0.04% polyvinylpyrollidone, 0.04% BSA, 0.04% Ficoll, 
5 x SSC (1 x SSC: 0.15 M NaCl, 0.015 M sodium citrate), 1% SDS, 
200 pg/ml sheared, denatured salmon sperm DNA (Sigma Chemical 
Co.) and 2 fig/ml polyA and 1 pg/ml polyG (Sigma Chemical Co.). 
Hybridization was carried out in the same solution for 20 h with an 
electrophoretically purified insert from the human ,muscle N-CAM 
cDNA clone A9.5 [7] labelled with [32P]deoxycytidine triphosphate 
(Amersham). Filters were washed with 2 x SSC, 0.1% SDS for 1 h 
at 42°C followed by washes at 2 x SSC, 1% SDS twice for 30 min 
at 65°C and then by 0.1 x SSC for 15 min at 20°C. Filters were then 
exposed to Kodak X-ray film (Xomat 5AR) at -70°C in the presence 
of an intensifying screen. 
2.2. Preparation of N-CAM protein and immunoblotting 
The procedure of Moore et al. [9] was followed with minor 
modifications. Briefly, the heart tissues were homogenized in 1% 
NP-4, solubilized in 20 mM Tris-HCl, 0.85% NaCl, pH 7.4, COR- 
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taining 2 U/ml Trasylol (Sigma) and 1 mM PMSF (Sigma) as pro- 
tease inhibitors. The homogenate was then centrifuged at 100000 x
g for 1 h at 4°C and the soluble supernatant was collected. The solu- 
ble fraction was then treated, for 1 h at 37”C, with neuraminidase 
(type X, Sigma) at a final concentration of 0.5 U/ml in 2.5 mM 
sodium acetate buffer, pH 5.0, to generate the desialo forms of N- 
CAM. The reaction was terminated by the addition of gel loading 
sample buffer [l l] containing SDS and 2-mercaptoethanol. 
Polyacrylamide gel separation was performed according to the pro- 
cedure described by Laemmli Ill], using 8.5% polyacrylamide gel. 
The resolved proteins were then electroblotted onto nitrocellulose 
(NC) membrane (Schleisher and Shuell, Anderman and Co.) accor- 
ding to the protocol of Towbin et al. [12], and treated with a 
monoclonal antibody to human N-CAM. 
2.3. Tissue processing and immunofluorescence staining 
Cryostat sections (lo-15 cm) were air-dried for 1 h, then fixed for 
10 min in methanol/acetone (1: 1). Sections were briefly washed in 
PBS and then immersed in Pontamine sky blue [13] for 30 min at 
room temperature. They were then washed with several changes of 
PBS for 45 min. Anti-human N-CAM mouse monoclonal antibody 
was added at a dilution of l/100 for 30 min at room temperature. 
The slides were then washed with PBS (3 changes) for 30 min. A se- 
cond antibody, sheep anti-mouse whole Ig conjugated to FITC 
(Sigma), was added and the slides were incubated for 1 h at room 
temperature. They were extensively washed with several changes of 
PBS. The slides were mounted and visualized. Control sections were 
processed in the same way except using normal mouse’serum as the 
first antibody. 
3. RESULTS AND DISCUSSION 
Fig. 1 shows the Northern blot analysis of RNA 
from human heart of various fetal ages (13-17 weeks) 
as well as that derived from mature left ventricular 
myocardium (mature right ventricle gave a similar pat- 
tern; results not shown) and probed with the human 
muscle N-CAM cDNA probe, X9.5. We found at least 
5 transcripts; these were of 7.2, 6.7, 5.2, 4.3 and 
2:9 kb, respectively. These transcripts represent a full 
complement corresponding to those previously describ- 
ed in mouse brain [14], although only the 7.2, 6.7 and 
4.3 kb transcripts appear during embryonic life [5] with 
the 5.2 and 2.9 transcripts appearing only postnatally. 
N-CAM transcript size has not previously been 
reported in heart for any mammalian species. 
However, Prediger et al. [15] have described mRNA 
transcripts of 6.4, 4.3 and 3 kb in chicken cardiac 
tissue. We not only report that all 5 transcripts are ex- 
pressed in fetal and mature human heart, but also show 
that the level of expression, particularly of the 5.2 kb 
transcript, progressively increased with gestational age 
and had increased even more in mature myocardium. 
This pattern of development may be related to the 
hypoplastic requirement and progressive differentia- 
tion of embryonic myocytes; a process which is com- 
plete and ceases soon after term. 
Fig. 2 (Western blotting) shows the reaction pattern 
of the desialylated N-CAM isoforms using the im- 
munoblotting technique. All fetal samples showed 
similar reactive protein bands at apparent molecular 
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Fig. 1. Northern blot analysis of human cardiac N-CAM, with the 
wholeh9.5 cDNA probe, using 10 rg of total RNA from human fetal 
and mature human heart. (Lane 1) 13.4 weeks gestation; (lane 2) 14.3 
weeks gestation; (lane 3) a lymphoblastoid cell line; (lane 4) 15.5 
weeks gestation; (lane 5) 16.3 weeks gestation; (lane 6) 16.6 weeks 
gestation; (lane 7) 17 weeks gestation; and (lane 8) left ventricle from 
a 5-year-old cystic fibrosis transplant. The positions of the 28 S and 
18 S rRNA standards are shown on the right, and the sizes of N- 
CAM transcripts are indicated on the left in kb. Gestation ages were 
calculated by the Royal Marsden Tissue Bank. 
contrast, adult heart left ventricle (LV), revealed only 
two immunoreactive bands with the anti-human N- 
CAM antibody. These two polypeptides are of ap- 
parent molecular masses of 125 and 105 kDa (Fig. 2, 
lane 6) with the larger polypeptide giving the strongest 
signal. A mouse fibroblast cell line (3T3) transfected 
with human N-CAM gave only the 125 kDa band. 
Thus, we found that human heart showed a different 
pattern of N-CAM expression to that in rat heart [4] 
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Fig. 2. Western blot analysis of neuraminidase-treated desialo N- 
CAM isoforms in fetal and mature human heart tissue. (Lane 1). 3T3 
mouse Bbroblast cell line transfected with human N-CAM; (lane 2) 
11.4 weeks gestation; (lane 3) 14.0 weeks gestation; (lane 4) 14.8 
weeks gestation; (lane 5) 16.6 weeks gestation; (lane 6) left ventricle 
from a 5-year-old cystic fibrosis transplant. Molecular mass markers 
are shown on the right; sizes of N-CAM polypeptides from fetal, on 
the left, and from mature hearts (arrows) on the right (in kDa). 
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Fig. 3. N-CAM immunofluorescence staining in fetal and mature 
human myocardium. (a) Fetal myocytes; 14.0 weeks gestation. (b) 
Mature myocytes; left ventricle from a 5-year-old transplanted for 
cystic fibrosis. Bar = 10rm. 
where, after the appearance during embryonic life of 
N-CAM isoforms corresponding to 105 and 145 kDa, 
they are replaced postnatally by isoforms of 125 and 
155 kDa. A similar pattern has been found during 
development in mouse skeletal muscle [9]. As in these 
studies, we also noted the postnatal appearance of a 
125 kDa isoform, but we found all fetal isoforms to be 
of different sizes when comparing rodent and human. 
In the mouse, the expression of the N-CAM isoforms 
is believed to be controlled on the gene level by alter- 
native splicing in combination with the use of different 
polyadenylation sites [16]. In the present study, fetal 
heart N-CAM shows 3 isoforms, with two different 
isoforms appearing in mature myocardium. This does 
not reflect a post-translational glycosylation difference 
since the samples were desialylated prior to their reac- 
tion with the anti-human N-CAM monoclonal an- 
tibody. 
Cardiac cells exhibited intense immunofluorescent 
staining along the sarcolemma, using anti-human N- 
CAM monoclonal antibody, on frozen and fixed sec- 
tions at 14 weeks gestation (and beyond) (Fig. 3a). A 
similar reaction was also noted in sections from mature 
heart (Fig. 3b). The validity of these im- 
munofluorescence studies was confirmed using im- 
munoperoxidase staining (results not shown). A similar 
sarcolemmal pattern of N-CAM localization has 
recently been reported [4] in developing rat heart. In 
both rat and human, there is clearly a different level of 
appropriate N-CAM expression during the various 
stages of development in fetal and mature myocar- 
dium. In part, this may reflect the postnatal change 
from dividing to non-dividing myocytes and the 
development of a fully mature syncytium. The dif- 
ference in N-CAM expression may also be related to the 
postnatal development of the adrenergic supply to the 
heart. What is clear is that N-CAM is subject to tem- 
poral regulation in the developing heart and that the 
precise pattern of expression differs markedly between 
species. 
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